Compounds with MDR1-inverse activity

Details for Australian Patent Application No. 2009213153 (hide)

Owner The Government of the United States of America as Represented by The Secretary of The Department of Health and Human Services Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences

Inventors Hall, Matthew D.; Szakacs, Gergely; Gottesman, Michael M.; Hellawell, Jennifer L.; Fales, Henry M.; Salam, Noeris K.; Ludwig, Joseph A.

Agent Fisher Adams Kelly

Pub. Number AU-A-2009213153

PCT Pub. Number WO2009/102433

Priority 61/027,712 11.02.08 US

Filing date 10 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 31/404 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/102433 Priority application(s): WO2009/102433

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009213154-Peripheral overlap stent

2009213151-Searchable electronic records of underground facility locate marking operations